424 related articles for article (PubMed ID: 27859048)
1. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
2. Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
J Immunol; 2011 Mar; 186(6):3779-86. PubMed ID: 21317396
[TBL] [Abstract][Full Text] [Related]
3. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
4. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
5. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
6. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated pancreatic overexpression of
Mallol C; Casana E; Jimenez V; Casellas A; Haurigot V; Jambrina C; Sacristan V; Morró M; Agudo J; Vilà L; Bosch F
Mol Metab; 2017 Jul; 6(7):664-680. PubMed ID: 28702323
[TBL] [Abstract][Full Text] [Related]
9. Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35.
Bettini M; Castellaw AH; Lennon GP; Burton AR; Vignali DA
Diabetes; 2012 Jun; 61(6):1519-26. PubMed ID: 22427377
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
11. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
Zhang YC; Pileggi A; Agarwal A; Molano RD; Powers M; Brusko T; Wasserfall C; Goudy K; Zahr E; Poggioli R; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick H; Flotte T; Ellis TM; Ricordi C; Inverardi L; Atkinson MA
Diabetes; 2003 Mar; 52(3):708-16. PubMed ID: 12606512
[TBL] [Abstract][Full Text] [Related]
14. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
Goudy KS; Burkhardt BR; Wasserfall C; Song S; Campbell-Thompson ML; Brusko T; Powers MA; Clare-Salzler MJ; Sobel ES; Ellis TM; Flotte TR; Atkinson MA
J Immunol; 2003 Sep; 171(5):2270-8. PubMed ID: 12928371
[TBL] [Abstract][Full Text] [Related]
15. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
16. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
17. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells.
Flores RR; Zhou L; Robbins PD
Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.
Li L; Yi Z; Wang B; Tisch R
J Immunol; 2009 Oct; 183(7):4809-16. PubMed ID: 19752238
[TBL] [Abstract][Full Text] [Related]
19. AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice.
Rehman KK; Trucco M; Wang Z; Xiao X; Robbins PD
Mol Ther; 2008 Aug; 16(8):1409-16. PubMed ID: 18560422
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
